» Articles » PMID: 23748231

Comparison of Two Different IMRT Planning Techniques in the Treatment of Nasopharyngeal Carcinoma. Effect on Parotid Gland Radiation Doses

Overview
Specialties Oncology
Radiology
Date 2013 Jun 11
PMID 23748231
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the effect of two different intensity-modulated radiation therapy (IMRT) planning techniques on parotid gland doses in patients with nasopharyngeal carcinoma (NPC).

Patients And Methods: Radiotherapy for 10 NPC patients referred to the University of Istanbul Cerrahpasa Medical School was planned with arc- and static seven-field IMRT. The simultaneous integrated boost (SIB) technique was used to deliver 70 Gy (2.12 Gy per fraction) to the primary tumor and involved nodes; 60 Gy (1.81 Gy per fraction) to the entire nasopharynx and 54 Gy (1.63 Gy per fraction) to elective lymph nodes in 33 fractions. Plans also aimed to keep the mean parotid dose below 26 Gy and limit the maximum doses to the spinal cord and brain stem to 45 and 54 Gy, respectively. Mean parotid gland doses for the two planning techniques were compared using a paired t-test. Target coverage and dose inhomogeneity were evaluated by calculating conformity- (CI) and homogeneity index (HI) values.

Results: Target coverage and dose homogeneity were identical and good for both planning techniques: CI = 1.05 ± 0.08 and 1.05 ± 0.08; HI = 1.08 ± 0.02 and 1.07 ± 0.01 for arc- and static field IMRT, respectively. Mean doses to contralateral parotid glands were 25.73 ± 4.27 and 27.73 ± 3.5 Gy(p = 0.008) for arc- and static field IMRT plans, respectively, whereas mean ipsilateral parotid doses were 30.65 ± 6.25 and 32.55 ± 5.93 Gy (non-significant p-value), respectively. Mean monitor units (MU) per fraction for the 10 patients were considerably lower for arc- than for static field treatments-540.5 ± 130.39 versus 1288.4 ± 197.28 (p < 0.001).

Conclusion: Normal tissues--particularly the parotid glands--are better spared with the arc technique in patients with NPC. MU and treatment times are considerably reduced in arc IMRT plans.

Citing Articles

Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.

Huang T, Tsai M, Chuang H, Chien C, Lin Y, Tsai W Radiat Oncol. 2020; 15(1):84.

PMID: 32307024 PMC: 7168825. DOI: 10.1186/s13014-020-01532-4.


Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.

Liao S, Xie Y, Feng Y, Zhou Y, Pan Y, Fan J J Cancer Res Clin Oncol. 2019; 146(2):429-439.

PMID: 31677113 DOI: 10.1007/s00432-019-03067-y.


Slug inhibition increases radiosensitivity of nasopharyngeal carcinoma cell line C666-1.

Yang H, Zhang G, Che X, Yu S Exp Ther Med. 2018; 15(4):3477-3482.

PMID: 29545871 PMC: 5840900. DOI: 10.3892/etm.2018.5844.


SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.

Gao J, Qian T, Tao C, Zhang Y, Zhou Y, Yang J Br J Radiol. 2015; 88(1053):20150052.

PMID: 26111068 PMC: 4743565. DOI: 10.1259/bjr.20150052.


Clinical and dosimetric evaluation of RapidArc versus standard sliding window IMRT in the treatment of head and neck cancer.

Smet S, Lambrecht M, Vanstraelen B, Nuyts S Strahlenther Onkol. 2014; 191(1):43-50.

PMID: 25168752 DOI: 10.1007/s00066-014-0742-x.


References
1.
Som P, Curtin H, Mancuso A . An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg. 1999; 125(4):388-96. DOI: 10.1001/archotol.125.4.388. View

2.
Aydogan B, Yeginer M, Kavak G, Fan J, Radosevich J, Gwe-Ya K . Total marrow irradiation with RapidArc volumetric arc therapy. Int J Radiat Oncol Biol Phys. 2011; 81(2):592-9. DOI: 10.1016/j.ijrobp.2010.11.035. View

3.
Corvo R . Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol. 2007; 85(1):156-70. DOI: 10.1016/j.radonc.2007.04.002. View

4.
Duthoy W, De Gersem W, Vergote K, Boterberg T, Derie C, Smeets P . Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys. 2004; 60(3):794-806. DOI: 10.1016/j.ijrobp.2004.04.016. View

5.
Mackenzie M, Robinson D . Intensity modulated arc deliveries approximated by a large number of fixed gantry position sliding window dynamic multileaf collimator fields. Med Phys. 2002; 29(10):2359-65. DOI: 10.1118/1.1508110. View